Anna Torrång has a BSc in Statistics from the University of Linköping, Sweden, and a long and broad experience (>25 years) from the pharmaceutical industry and epidemiological research at the Karolinska Institute in Stockholm. Within AstraZeneca she worked as a Global Product Statistician in projects within neuroscience and as a Group Manager for Biostatisticians. Her main expertise lies within clinical development, and the design and statistical analysis of clinical trials. Anna has worked at SDS since 2013, primarily as a senior biostatistical consultant in drug development and as the Director for SDS Biostatistics.
phone + 46 72 588 38 71